H2O Innovation Inc (TSXV: HEO) is a Canada-based company that provides water treatment solutions based on membrane filtration technology for municipal, energy, and natural resources end-users. The company has three divisions that are water technologies & services (WTS), specialty products, and operation and maintenance services(O&M).

Key highlights

• Acquired two O&M companies based in New York state: The company recently announced two acquisitions in the Northeast US, bolstering its Operation & Maintenance business line. Both deals are projected to be immediately accretive to H 2 O Innovation's net profits and EBITDA from a financial standpoint. These purchases bring the Corporation one step closer to the EBITDA objective stated in the 3-year Strategic Plan on a Pro-forma basis. The Targets produced CAD 17.0 million in revenue for the twelve months ended September 30, 2021, with Adjusted EBITDA of CAD 3.3 million and net profitability of CAD 1.3 million on a consolidated basis.

Source: Company Presentation

• Improved Backlog: On December 31, 2021, the company's combined backlog of secured contracts between WTS and O&M was CAD 126.2 million, up from CAD 112.0 million on December 31, 2020. This combined backlog provides excellent visibility on revenues for the coming quarters of the fiscal year 2022 and beyond. The business model that has been created over the years is also translating into a solid backlog that is evenly distributed between O&M and WTS contracts.

Source: Company Filing

• Stellar performance from O&M and Specialty Products segments: The company is generating almost 80% of its consolidated revenues from these two segments where the O&M segment contributed 46.8% in Q2 2022, while the Specialty products segment contributed 32.8% respectively. Organic growth of CAD 2.0 million, or 11.3%, and CAD 0.7 million from the purchase of JCO and EC effective December 15, 2021, boosted revenue from the O&M business pillar by CAD 2.1 million to CAD 19.6 million in Q2 2022, compared to the previous similar period. In comparison to pcp, revenues from the Specialty Products sector climbed by CAD 3.4 million to CAD 13.7 million in the same period, owing to the purchase of GMP.

Source: Company Filing 

Risks associated with investment

The performance of the company might be impacted due to a change in technology, entry of new players with value-added products at a competitive price leading to price competition and margin erosion, etc.

Financial Overview of Q2 2022 (in thousands of CAD)

Source: Company Filing

• In Q2 2022, the company reported higher revenue at CAD 42.0 million against CAD 34.9 million in the previous corresponding period. The increase was driven by strong momentum across all the business pillars.

• In the reported period the company stated a higher operating profit at CAD 1.3 million against CAD 0.9 million in the previous corresponding period. However, it witnessed elevated SG&A expenses at CAD 7.5 million V/s 5.8 million in pcp.

• The company’s net earnings stood at CAD 0.7million compared to CAD 0.2 million in pcp; this improvement was mainly due to higher operating profit and partially supported by lower income tax expense. 
  

Valuation Methodology (Illustrative): EV to Sales

Analysis by Kalkine Group 

Stock recommendation

The company's robust Q2 2022 financial results demonstrated that it is implementing its 3-Year Strategic Plan, with topline growth of 20.1% and good net profitability, despite the COVID-19 pandemic's persisting negative effects, including labor costs, raw material price rises, and supply chain difficulties. The company is investing continuously in the business to increase sales, grow through disciplined acquisitions, and use digital tools to improve profitability, and it is on track to meet its FY2024 goals of 10.0% year-over-year organic revenue growth and an EBITDA margin of above 11.0%.

Moreover, the group is also witnessing healthy growth in its backlog, which provides excellent visibility on revenues for the coming quarters of the fiscal year 2022 and beyond. Therefore, based on the above rationale and valuation, we recommend a “Speculative Buy” rating at the closing price of CAD 2.32 as on March 1, 2022. Moreover, the markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

One-Year Price Chart (as on March 1, 2022). Source: REFINITIV, Analysis by Kalkine Group

Technical Analysis Summary

Disclaimer

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.